Logo-apb
Adv Pharm Bull. 2024;14(3): 696-704. doi: 10.34172/apb.2024.045
PMID: 39494251        PMCID: PMC11530872

Research Article

Unlocking Therapeutic Potential: Enhanced shRNA Delivery with Tat Peptide in the Human Respiratory Syncytial Virus Treatment

Saeid Amiri Zadeh Fard 1,2 ORCID, Haniyeh Abuei 3 ORCID, Abbas Behzad Behbahani 1 ORCID, Gholamreza Rafiei Dehbidi 1 ORCID, Farahnaz Zare 1 ORCID, Maryam Nejabat 4 ORCID, Alireza Safarpour 2 ORCID, Ali Farhadi 1 * ORCID

Cited by CrossRef: 1

1- Faghirabadi F, Abuei H, Malekzadeh M, Mojiri A, Farhadi A. Intracellular delivery of antiviral shRNA using penetratin-based complexes effectively inhibits respiratory syncytial virus replication and host cell apoptosis. Virol J. 2024;21(1) [Crossref]

Journal Info:

Freq.: Quarterly

eISSN: 2251-7308 
pISSN: 2228-5881 

Permission: CC By

Platinum Open Access

(no submission or publication fees)

Powered by